Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.
Journal of Clinical Otolaryngology Head and Neck Surgery
The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery

J Clin Otolaryngol Head Neck Surg 1995; 6(1):69-76

pISSN: 1225-0244, eISSN: 2713-833X

DOI: https://doi.org/10.35420/jcohns.1995.6.1.69

원저

후두암의 임상적 고찰

이종덕1, 이강대1, 이우종1, 임용수1, 이봉희1, 이정삼1, 유태현1
A Clinical Study on the Laryngeal Cancer
Jong Duk Lee1, Kang Dae Lee1, Woo Chong Lee1, Yong Soo Yim1, Bong Hee Lee1, Cheong Sam Lee1, Tai Hyun Yu1
1고신대학교 의과대학 이비인후과학교실
1Department of Otolaryngology, College of Medicine, Kosin University

© Copyright 1995 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: May 31, 2020

ABSTRACT

The authors experienced 127 cases of laryngeal cancer for recent 8 years and analyzed treatment results as follows.

  1. Glottic region was predominant as 52.8%, supraglottic 46.5%, subglottic 0.7% and advanced cases such as stage III, IV were 69.3% of the patients.

  2. Cervical metastasis was observed 42.5% of the patients. The rate of cervical metastasis according to T-stage was 56.7% in T4, 48.9% in T3, 37.5% in T2 and 11.2% in T1. There were more common in supraglottic than glottic cancer about 4 times.

  3. Initial treatment modalities were surgery only in 20.5%, radiation only in 31.5%, and combined surgery with postoperative radiation in 45.7%.

  4. Overall 5-year survival rate was 52.6%, and showed 80.7% in stage I, 56.2% in stage II, 48.3% in stage III, and 44.8% in stage IV.

  5. Glottic cancer showed better prognosis (5-year survival rate 65.2%) than supraglottic cancer(5-year survival rate 39.6%).

  6. 5-year survival rate according to treatment modality was 78.7% in surgery only group, 53.8% in radiation only group, and 48.5% in surgery with postoperative radiation group.

  7. In cases of cervical metastasis, 5-year survival rate was decreased to 39.5%.

Keywords: Larygeal cancer; treatment modality; 5-year survival rate